Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)

John Radford; Andrew Davies; Guillaume Cartron; Franck Morschhauser; Gilles Andre Salles; Robert E. Marcus; Michael K. Wenger; Elina Asikanius; Elisabeth Wassner-Fritsch; Umberto Vitolo

doi:10.1182/blood.V118.21.270.270

Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)

John Radford, Andrew Davies, Guillaume Cartron, Franck Morschhauser, Gilles Andre Salles, Robert E. Marcus, Michael K. Wenger, Elina Asikanius, Elisabeth Wassner-Fritsch, Umberto Vitolo

Alliance Manchester Business School

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	124-125
Number of pages	2
Journal	Blood
Volume	118
Issue number	21
DOIs	https://doi.org/10.1182/blood.V118.21.270.270
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1182/blood.V118.21.270.270

Cite this

Radford, J., Davies, A., Cartron, G., Morschhauser, F., Salles, G. A., Marcus, R. E., Wenger, M. K., Asikanius, E., Wassner-Fritsch, E., & Vitolo, U. (2011). Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000). Blood, 118(21), 124-125. https://doi.org/10.1182/blood.V118.21.270.270

@article{320f1744a3fb480c951053b0a764067f,

title = "Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)",

author = "John Radford and Andrew Davies and Guillaume Cartron and Franck Morschhauser and Salles, {Gilles Andre} and Marcus, {Robert E.} and Wenger, {Michael K.} and Elina Asikanius and Elisabeth Wassner-Fritsch and Umberto Vitolo",

year = "2011",

doi = "10.1182/blood.V118.21.270.270",

language = "Undefined",

volume = "118",

pages = "124--125",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "21",

}

Radford, J, Davies, A, Cartron, G, Morschhauser, F, Salles, GA, Marcus, RE, Wenger, MK, Asikanius, E, Wassner-Fritsch, E & Vitolo, U 2011, 'Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)', Blood, vol. 118, no. 21, pp. 124-125. https://doi.org/10.1182/blood.V118.21.270.270

TY - JOUR

T1 - Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma

T2 - Final Results of the Phase I GAUDI Study (BO21000)

AU - Radford, John

AU - Davies, Andrew

AU - Cartron, Guillaume

AU - Morschhauser, Franck

AU - Salles, Gilles Andre

AU - Marcus, Robert E.

AU - Wenger, Michael K.

AU - Asikanius, Elina

AU - Wassner-Fritsch, Elisabeth

AU - Vitolo, Umberto

PY - 2011

Y1 - 2011

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000299597100271&KeyUID=WOS:000299597100271

U2 - 10.1182/blood.V118.21.270.270

DO - 10.1182/blood.V118.21.270.270

M3 - Article

SN - 0006-4971

VL - 118

SP - 124

EP - 125

JO - Blood

JF - Blood

IS - 21

ER -

Obinutuzumab (GA101) in Combination with FC or CHOP in Patients with Relapsed or Refractory Follicular Lymphoma: Final Results of the Phase I GAUDI Study (BO21000)

UN SDGs

Access to Document

Other files and links

Cite this